US equities
|
MU
$906.32
▲+0.16%
NVDA
$216.90
▼-0.09%
SPCX
$148.15
▲+0.13%
TSLA
$374.79
▲+1.83%
META
$690.29
▼-2.15%
SNDK
$1,376.40
▲+0.39%
AAPL
$340.09
▼-0.83%
INTC
$92.45
▲+0.46%
MU
$906.32
▲+0.16%
NVDA
$216.90
▼-0.09%
SPCX
$148.15
▲+0.13%
TSLA
$374.79
▲+1.83%
META
$690.29
▼-2.15%
SNDK
$1,376.40
▲+0.39%
AAPL
$340.09
▼-0.83%
INTC
$92.45
▲+0.46%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Nicholas Kadysh
Recent news which mentions Nicholas Kadysh
PharmAla Biotech To Supply LaNeo MDMA For Mt. Sinai Clinical Trial
October 21, 2024
Tickers
MDMA
MDXXF
Tags
MDMA/assisted therapy
Benzinga
CCrest Labs
From
Benzinga
PharmAla Biotech To Supply University Of Texas, San Antonio For Clinical Trial
October 08, 2024
Tickers
MDMA
MDXXF
NEWS
Tags
MDMA
Psychedelics
MDXXF
From
Benzinga
PharmAla Biotech Partners With Johns Hopkins University For MDMA Clinical Trials, Terminates Red Light Holland Contract
September 11, 2024
Tickers
MDMA
MDXXF
NEWS
TRUFF
Tags
Harpreet Kaur
Market News
Psychedelic Research
From
Benzinga